LBF20406AM30: Difference between revisions

Latest revision as of 04:47, 21 October 2010

Upper classes: LB LBF

N-Propyl-α-methylarachidonoylamide

Structural Information
	N-Propyl-α-methyl- (cis-5,cis-8,cis-11,cis-14) -eicosatetraenoylamine
	N-Propyl-α-methylarachidonoylamide N-Propyl-α-methyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine

Formula	C24H41NO
Exact Mass	359.318814939
Average Mass	359.58847999999995
SMILES	`C(C=CCCC(C)C(=O)NCCC)C=CCC=CCC=CCCCCC`
Physicochemical Information
	colorless oil Sheskin_T et al.






	This compound was synthesized from arachidonic acid and propylamine. Yield 84 %. Sheskin_T et al.

	Binding to the brain cannabinoid receptor (CBl), Ki(nM)= 7.4±0.2 Sheskin_T et al.


Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra	¹H NMR (CDCl3) δ 5.20-5.45 (m,
Other Spectra
Chromatograms

Reported Metabolites, References

Biospecies	ID	Compound Name	Reference	Comment
n.a.	LBF20406AM30	See above.	Sheskin_T et al. 1997

@@ Line 1: / Line 1: @@
+{{Lipid/Header}}
 {{Hierarchy|{{PAGENAME}}}}
@@ Line 4: / Line 6: @@
 |LipidBank=XPR7047
 |LipidMaps=LMFA08020033
-|SysName=N-propyl alpha-methyl arachidonoyl amide
+|SysName=N-Propyl-alpha-methyl- (cis-5,cis-8,cis-11,cis-14) -eicosatetraenoylamine
+|Common Name=&&N-Propyl-alpha-methylarachidonoylamide&&N-Propyl-alpha-methyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine&&
 |Melting Point=colorless oil [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
-|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H NMR (CDCl3) <FONT FACE="Symbol">d</FONT>5.20-5.45 (m,
+|NMR Spectra=^1 H NMR (CDCl3)  delta 5.20-5.45 (m,
+|Source=
+|Chemical Synthesis=This compound was synthesized from arachidonic acid and propylamine. Yield 84 %. [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
+|Metabolism=
+|Biological Activity=Binding to the brain cannabinoid receptor (CBl), Ki(nM)= 7.4±0.2 [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
 }}
+{{Lipid/Footer}}